Parkman Healthcare Partners LLC quarter change: USA Stocks, Reduced
In share positions in stocks (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Parkman Healthcare Partners LLC opened 17 positions, added to 26, reduced 30, sold out of 29 and left 1 unchanged. The largest increase in value was INBX (+$24,346,013); the largest decrease was KALV (-$36,948,736).
- SYK: Country of operation United States; Class COM; Shares 2026-03-31 154,771; Shares 2026-06-30 67,973.
- BSX: Country of operation United States; Class COM; Shares 2026-03-31 448,768; Shares 2026-06-30 180,481.
- PODD: Country of operation United States; Class COM; Shares 2026-03-31 156,561; Shares 2026-06-30 131,378.
- LIVN: Country of operation —; Class SHS; Shares 2026-03-31 403,965; Shares 2026-06-30 210,529.
Two Form 13F-HR filings compared (SEC CIK 1777015): 2026-03-31 (filed 2026-05-15) and 2026-06-30 (filed 2026-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2026-03-31 | Shares 2026-06-30 | Share change | Value 2026-03-31 | Value 2026-06-30 | Value change |
|---|
SYK
STRYKER CORPORATION | United States | COM | 154,771 | 67,973 | -86,798 | $50,856,203 | $21,400,619 | -$29,455,584 |
|---|
BSX
BOSTON SCIENTIFIC CORP | United States | COM | 448,768 | 180,481 | -268,287 | $28,160,192 | $7,702,929 | -$20,457,263 |
|---|
PODD
INSULET CORP | United States | COM | 156,561 | 131,378 | -25,183 | $32,852,760 | $20,002,301 | -$12,850,459 |
|---|
LIVN
LIVANOVA PLC | | SHS | 403,965 | 210,529 | -193,436 | $25,676,015 | $17,311,800 | -$8,364,215 |
|---|
DXCM
DEXCOM INC | United States | COM | 689,822 | 534,767 | -155,055 | $43,320,822 | $36,016,557 | -$7,304,265 |
|---|
WAY
WAYSTAR HLDG CORP | United States | COM | 443,058 | 203,986 | -239,072 | $10,682,128 | $4,187,833 | -$6,494,295 |
|---|
AORT
ARTIVION INC | United States | COM | 252,014 | 138,940 | -113,074 | $9,228,753 | $3,121,982 | -$6,106,771 |
|---|
ATEC
ALPHATEC HLDGS INC | United States | COM NEW | 823,763 | 449,943 | -373,820 | $8,962,541 | $3,892,007 | -$5,070,534 |
|---|
XENE
XENON PHARMACEUTICALS INC | | COM | 497,035 | 397,379 | -99,656 | $28,902,585 | $23,985,796 | -$4,916,789 |
|---|
ANIP
ANI PHARMACEUTICALS INC | United States | COM | 280,575 | 202,907 | -77,668 | $21,576,218 | $16,796,641 | -$4,779,577 |
|---|
ABSI
ABSCI CORPORATION | United States | COM | 1,864,806 | 894,374 | -970,432 | $5,594,418 | $10,365,795 | +$4,771,377 |
|---|
ZBH
ZIMMER BIOMET HOLDINGS INC | United States | COM | 269,557 | 232,557 | -37,000 | $24,373,344 | $20,020,832 | -$4,352,512 |
|---|
NVST
ENVISTA HOLDINGS CORPORATION | United States | COM | 711,693 | 553,916 | -157,777 | $18,055,651 | $14,595,687 | -$3,459,964 |
|---|
ADPT
ADAPTIVE BIOTECHNOLOGIES COR | United States | COM | 551,815 | 486,984 | -64,831 | $7,659,192 | $10,445,807 | +$2,786,615 |
|---|
OPRX
OPTIMIZERX CORP | United States | COM NEW | 729,369 | 350,347 | -379,022 | $4,580,437 | $2,003,985 | -$2,576,452 |
|---|
RCUS
ARCUS BIOSCIENCES INC | United States | COM | 1,207,274 | 919,266 | -288,008 | $26,077,118 | $28,340,971 | +$2,263,853 |
|---|
SNDX
SYNDAX PHARMACEUTICALS INC | United States | COM | 901,511 | 877,256 | -24,255 | $21,059,297 | $19,176,816 | -$1,882,481 |
|---|
ERAS
ERASCA INC | United States | COM | 406,702 | 258,684 | -148,018 | $6,580,438 | $4,739,091 | -$1,841,347 |
|---|
AMLX
AMYLYX PHARMACEUTICALS INC | United States | COM | 621,458 | 398,782 | -222,676 | $8,638,266 | $7,162,125 | -$1,476,141 |
|---|
URGN
UROGEN PHARMA LTD | | COM | 275,000 | 174,064 | -100,936 | $4,944,500 | $6,405,555 | +$1,461,055 |
|---|
MMED
MINIMED GROUP INC | United States | COM | 317,324 | 226,446 | -90,878 | $4,734,474 | $3,385,368 | -$1,349,106 |
|---|
EYPT
EYEPOINT INC | United States | COM NEW | 1,354,800 | 1,288,163 | -66,637 | $17,463,372 | $18,420,731 | +$957,359 |
|---|
CDNA
CAREDX INC | United States | COM | 291,378 | 202,417 | -88,961 | $5,058,322 | $5,768,885 | +$710,563 |
|---|
SIBN
SI BONE INC | United States | COM | 373,553 | 328,686 | -44,867 | $4,717,974 | $5,364,156 | +$646,182 |
|---|
VIR
VIR BIOTECHNOLOGY INC | United States | COM | 500,000 | 475,279 | -24,721 | $4,480,000 | $4,843,093 | +$363,093 |
|---|
ENTX
ENTERA BIO LTD | | SHS | 288,670 | 274,497 | -14,173 | $320,424 | $485,860 | +$165,436 |
|---|
LUNG
PULMONX CORP | United States | COM | 755,636 | 646,564 | -109,072 | $974,770 | $840,533 | -$134,237 |
|---|
ANNX
ANNEXON INC | United States | COM | 674,013 | 641,029 | -32,984 | $3,734,032 | $3,660,276 | -$73,756 |
|---|
OVID
OVID THERAPEUTICS INC | United States | COM | 208,205 | 197,947 | -10,258 | $462,215 | $532,477 | +$70,262 |
|---|
BCRX
BIOCRYST PHARMACEUTICALS INC | United States | COM | 1,708,099 | 1,624,279 | -83,820 | $16,261,102 | $16,242,790 | -$18,312 |
|---|